BOSTON and LAUSANNE, Switzerland, June 15,
2022 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq:
SOPH) ("the Company"), today announced that the Company has
published its first Environmental, Social and Governance Impact
Summary ("ESG Impact Summary"). The ESG Impact Summary highlights
the Company's policies, ongoing practices, and recent initiatives
across a range of areas including innovation and access, protecting
patient data, empowering its people, as well as other key priority
areas. The ESG Impact Summary is available on SOPHiAGENETICS.COM,
in the Investor Relations section.
"We are thrilled to be taking the first steps in SOPHiA
GENETICS' ESG journey. We place patient care at the heart of all
our decisions. Our success is deeply rooted in our core values and
the positive impact we have in the ESG areas across all levels of
the organization. This is critical to our mission of creating a
wiser and more sustainable healthcare system," said Dr. Jurgi
Camblong, Co-Founder and CEO at SOPHiA GENETICS.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology
company dedicated to establishing the practice of data-driven
medicine as the standard of care and for life sciences research. It
is the creator of the SOPHiA DDM™ Platform, a cloud-native platform
capable of analyzing data and generating insights from complex
multimodal data sets and different diagnostic modalities. The
SOPHiA DDM™ Platform and related solutions, products and services
are currently used by more than 790 hospital, laboratory, and
biopharma institutions globally. For more information, visit
SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn and Instagram.
Where others see data, we see answers.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/sophia-genetics-publishes-environmental-social-and-governance-impact-summary-301568678.html
SOURCE SOPHiA GENETICS